Japan has begun Phase I human clinical trials for a tooth-regrowth drug known as TRG-035, marking a significant step in regenerative dental medicine.
The treatment works by inhibiting the USAG-1 protein, which normally suppresses tooth development, with the goal of activating dormant tooth buds and stimulating new tooth growth.
The trials began in late 2024 at Kyoto University Hospital and Kitano Hospital. In the initial phase, researchers are evaluating the safety of the drug in 30 healthy adult male participants aged 30 to 64. Phase I trials are primarily designed to assess safety and tolerability before expanding to broader patient groups.
The research follows promising results in animal studies, where blocking USAG-1 successfully triggered tooth regrowth in mice and ferrets.
Scientists observed that inhibiting the protein allowed latent tooth buds to develop into functional teeth, suggesting potential application in humans.
If early safety trials prove successful, researchers plan to expand testing to children with congenital tooth agenesis, a condition in which individuals are born missing certain teeth.
This population is considered a key target group for the therapy, as current treatments typically rely on prosthetics or surgical interventions.
Tooth loss affects millions of people worldwide due to injury, decay, or genetic conditions. Current solutions include implants, dentures, and bridges, which restore function but do not regenerate natural teeth.
A successful regenerative drug could offer a biological alternative that encourages the body to grow new teeth naturally.
Researchers have indicated that, if clinical trials progress as planned and regulatory approvals are secured, the treatment could potentially become available around 2030.
However, experts caution that multiple trial phases remain, including larger efficacy studies to confirm effectiveness and long-term safety.
While still in early stages, the development represents a broader shift toward regenerative medicine, where therapies aim to restore or regrow tissues rather than replace them artificially.
Dental professionals and scientists are closely monitoring the progress of the trials, as successful human results could transform the future of oral healthcare….See More
Leave a Reply